Author

M. Garayoa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Garcia-Gomez· 1 shared C. Ortiz de Solorzano· 1 shared E. Ballestar· 1 shared E. San Jose-Eneriz· 1 shared F. Catala-Moll· 1 shared F. Prosper· 1 shared J. Oyarzabal· 1 shared J. Rodriguez-Ubreva· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Garcia-Gomez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

A. Garcia-Gomez, T. Li, J. Rodriguez-Ubreva, L. Ciudad, F. Catala-Moll, M. Martin, L. San-Segundo, X. Morales, C. Ortiz de Solorzano, J. Oyarzabal, E. San Jose-Eneriz, X. Agirre, F. Prosper, M. Garayoa, E. Ballestar

This study identifies aberrant DNA methylation in mesenchymal stromal cells from myeloma patients and shows that targeting DNMTs and G9a with CM-272 reverses bone loss and reduces tumor burden.

bioRxiv · Sep 12, 2019Cancer Biology